Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

AIDS may cause changes in the scalp that increase infection risk and hair loss.

Cilostazol may help hair grow and could be a new treatment for hair loss.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

Scientists can control how skin stem cells divide by using different treatments.

Dermal Wnt/β-catenin signaling is important for the proper size and development of hair follicles.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

DGAT1 enzyme helps make diacylglycerols, waxes, and retinyl esters.

NK cells play a role in skin diseases like eczema and psoriasis.

New treatments like nanotechnology show promise in improving skin cancer therapy.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

ADAM17 could be a potential target for treating PCOS.

β-catenin is essential for stem cell activation and proliferation in hair follicles.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.